Thomas Licht
Impact in
- Oncology top 5%
- Drug Transport and Resistance Mechanisms
- Ophthalmology top 2%
- Ocular Diseases and Behçet’s Syndrome
Papers in
- Oncology 35
- Drug Transport and Resistance Mechanisms 19
- Cancer survivorship and care 9
-
- RNA Interference and Gene Delivery 10
- Cancer therapeutics and mechanisms 8
- Co-authors
- Ira Pastan (15 shared papers)Michael M. Gottesman (11 shared papers)M M Gottesman (4 shared papers)Christian Peschel (9 shared papers)F. Herrmann (5 shared papers)Carol Cardarelli (2 shared papers)Timothy C. Chambers (1 shared paper)Ursula A. Germann (1 shared paper)
- Journals
- Blood (4 papers)Human Gene Therapy (3 papers)Diabetes (3 papers)Journal of Clinical Oncology (3 papers)International Journal of Cancer (3 papers)
- Partner nations
- GermanyUnited StatesAustria
In The Last Decade
Thomas Licht
62 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 97
- Oncology 635
- Ophthalmology 179
- Gastroenterology 62
- Hepatology 82
- Molecular Biology 695
Countries citing papers authored by Thomas Licht
This map shows the geographic impact of Thomas Licht's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Licht with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Licht more than expected).
Fields of papers citing papers by Thomas Licht
This network shows the impact of papers produced by Thomas Licht. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Licht. The network helps show where Thomas Licht may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Licht, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 63 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 193 | |
| 2 | 1996 | 149 | |
| 3 | 2014 | 120 | |
| 4 | 2006 | 98 | |
| 5 | 2009 | 97 | |
| 6 | 2001 | 95 | |
| 7 | 1996 | 91 | |
| 8 | 2004 | 83 | |
| 9 | Chemotherapy and chemosensitization of transgenic mice which express the human multidrug resistance gene in bone marrow: efficacy, potency, and toxicity. | 1991 | 72 |
| 10 | 1994 | 51 | |
| 11 | 2003 | 51 | |
| 12 | 1991 | 43 | |
| 13 | 2012 | 39 | |
| 14 | 1995 | 36 | |
| 15 | 2002 | 36 | |
| 16 | 2002 | 28 | |
| 17 | 1985 | 27 | |
| 18 | 1997 | 27 | |
| 19 | 2000 | 25 | |
| 20 | 2017 | 25 |
About Thomas Licht
Thomas Licht is a scholar working on Oncology, Molecular Biology, Pediatrics, Perinatology and Child Health, Epidemiology and Radiology, Nuclear Medicine and Imaging, having authored 63 papers that have together received 1.8k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (19 papers), RNA Interference and Gene Delivery (10 papers), Cancer survivorship and care (9 papers), Cancer therapeutics and mechanisms (8 papers), Hepatitis B Virus Studies (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers), Virus-based gene therapy research (6 papers) and Pharmacological Effects and Toxicity Studies (5 papers). The work is most often cited by research in Oncology (635 citations), Ophthalmology (179 citations), Gastroenterology (62 citations), Hepatology (82 citations) and Molecular Biology (695 citations). Thomas Licht has collaborated with scholars based in Germany, United States and Austria. Frequent co-authors include Ira Pastan, Michael M. Gottesman, M M Gottesman, Christian Peschel, F. Herrmann, Carol Cardarelli, Timothy C. Chambers, Ursula A. Germann, Suresh V. Ambudkar and Karin Mayer. Their work appears in journals such as Blood, Human Gene Therapy, Diabetes, Journal of Clinical Oncology and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.